Stay updated on CD19 CAR T Cell Therapy in Adult ALL Clinical Trial
Sign up to get notified when there's something new on the CD19 CAR T Cell Therapy in Adult ALL Clinical Trial page.
Latest updates to the CD19 CAR T Cell Therapy in Adult ALL Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements in the latest release.SummaryDifference0.3%
- Check8 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference4%
- Check16 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check23 days agoChange DetectedNew content was added on September 3, 2024, following the deletion of previous content on September 2, 2024.SummaryDifference0.3%
- Check30 days agoChange DetectedThe latest addition includes a revised study on CD19 targeted CAR T cell therapy for adult patients with relapsed or refractory B cell acute lymphoblastic leukaemia, updating from the previous version.SummaryDifference1%
- Check51 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.3%
Stay in the know with updates to CD19 CAR T Cell Therapy in Adult ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19 CAR T Cell Therapy in Adult ALL Clinical Trial page.